Haemoblock hemostatic substance in reducing seroma formation post axillary lymph node dissection following breast conserving surgery.

Autor: Isahak MI; Department of Surgery, Faculty of Medicine, Universiti Teknologi MARA, Sungai Buloh, Selangor, Malaysia., Abdullah MS; Department of Surgery, Faculty of Medicine, Universiti Teknologi MARA, Sungai Buloh, Selangor, Malaysia., Awang RR; Breast and Endocrine Unit, Department of Surgery, Hospital Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Kuala Lumpur, Malaysia., Abdul Rashid NF; Breast and Endocrine Unit, Department of Surgery, Faculty of Medicine, Universiti Teknologi MARA, Sungai Buloh, Selangor, Malaysia., Md Sikin S; Breast and Endocrine Unit, Department of Surgery, Hospital Sultan Ismail, Johor Bahru, Malaysia., Abdullah Suhaimi SN; Breast and Endocrine Unit, Department of Surgery, Hospital Canselor Tuanku Muhriz UKM, Cheras, Kuala Lumpur, Malaysia., Abdullah N; Breast and Endocrine Unit, Department of Surgery, Hospital Canselor Tuanku Muhriz UKM, Cheras, Kuala Lumpur, Malaysia., Muhammad R; Breast and Endocrine Unit, Department of Surgery, Hospital Canselor Tuanku Muhriz UKM, Cheras, Kuala Lumpur, Malaysia., Md Latar NH; Breast and Endocrine Unit, Department of Surgery, Hospital Canselor Tuanku Muhriz UKM, Cheras, Kuala Lumpur, Malaysia.
Jazyk: angličtina
Zdroj: World journal of surgery [World J Surg] 2024 May; Vol. 48 (5), pp. 1159-1166. Date of Electronic Publication: 2024 Apr 05.
DOI: 10.1002/wjs.12134
Abstrakt: Background: Axillary lymph node dissection (ALND) in breast cancer management, necessitates a nuanced understanding of complications that may impede treatment progression. This study scrutinize the impact of Haemoblock hemostatic solution, evaluation it's potential in reducing seroma complication by controlling lymph flow and obliterating axillary dead space.
Method: A prospective, randomized, double-blinded controlled trial was conducted with 58 patients undergoing breast conserving surgery (BCS) and ALND, stratified into two groups: Group A (ALND + Haemoblock, n = 29) and Group B (ALND + placebo, n = 29). Postoperative drainage charts were monitored, with the primary endpoint being the time to drain removal, Additionally, patients were observed for surgical site infection (SSI).
Results: Group A exhibited a marginally higher mean total drain output (398 +/- 205 vs. 326 +/- 198) compared to Group B, this difference did not attain statistical significance (p = 0.176). Equally, the mean time to drain removal demonstrated no discernible distinction between the two groups (6 +/- 3.0 vs. 6 +/- 3.0, Group A vs. Group B, p = 0.526). During follow up, nine patients in Group A required seroma aspiration (mean aspiration 31 +/- 73) as compared to Group B, 6 patients required aspiration (mean aspiration 12 +/- 36), p = 0.222). No notable disparity in SSI rates between the groups was identified.
Conclusion: In conclusion, the administration of Haemoblock did not manifest a discernible effect in mitigating seroma production, hastening drain removal, or influencing SSI rates following ALND. The study underscores the intricate and multifactorial nature of seroma formation, suggesting avenues for future research to explore combined interventions and protracted follow-up periods for a more comprehensive understanding.
(© 2024 International Society of Surgery/Société Internationale de Chirurgie (ISS/SIC).)
Databáze: MEDLINE
Externí odkaz: